ARTICLE | Company News
Ajinomoto Pharmaceuticals Co. Ltd., Eisai, Takeda sales and marketing update
March 11, 2013 7:00 AM UTC
Ajinomoto and Eisai announced the launch of once-monthly 75 mg Actonel/ Benet risedronate in Japan to treat osteoporosis. Japan's National Health Insurance (NHI) listed the antiresorptive pyridinyl b...